PT90227A - Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metileno - Google Patents
Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metilenoInfo
- Publication number
- PT90227A PT90227A PT90227A PT9022789A PT90227A PT 90227 A PT90227 A PT 90227A PT 90227 A PT90227 A PT 90227A PT 9022789 A PT9022789 A PT 9022789A PT 90227 A PT90227 A PT 90227A
- Authority
- PT
- Portugal
- Prior art keywords
- alpha
- hydroxy
- preparation
- methylene steroids
- steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88200675 | 1988-04-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT90227A true PT90227A (pt) | 1989-11-10 |
| PT90227B PT90227B (pt) | 1994-06-30 |
Family
ID=8199778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT90227A PT90227B (pt) | 1988-04-08 | 1989-04-07 | Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metileno |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5194602A (pt) |
| EP (1) | EP0336521B1 (pt) |
| JP (1) | JP2812397B2 (pt) |
| KR (1) | KR0138777B1 (pt) |
| CN (2) | CN1032211C (pt) |
| AU (1) | AU618350B2 (pt) |
| CA (1) | CA1332409C (pt) |
| DE (1) | DE68901104D1 (pt) |
| DK (1) | DK175401B1 (pt) |
| ES (1) | ES2033516T3 (pt) |
| FI (1) | FI108436B (pt) |
| GR (1) | GR3004539T3 (pt) |
| HU (1) | HU208437B (pt) |
| IE (1) | IE62277B1 (pt) |
| IL (1) | IL89880A (pt) |
| NO (1) | NO300894B1 (pt) |
| PT (1) | PT90227B (pt) |
| WO (1) | WO1989009781A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA909444B (en) * | 1989-11-27 | 1991-08-28 | Schering Corp | Process for dehydrating corticosteroid intermediates |
| FR2677029B1 (fr) * | 1991-05-23 | 1994-01-21 | Roussel Uclaf | Nouveaux derives sterouides de l'andostra-4,9(11),16-trien-3-one. |
| FR2676740B1 (fr) * | 1991-05-23 | 1993-11-05 | Roussel Uclaf | Nouveaux derives sterouides du pregna-4,9(11),17(20)-trie-3-one, leur preparation, leur application a la preparation de composes sterouides de type pregna-4,9(11),16-triene-3,20-dione et nouveaux intermediaires. |
| FR2677028B1 (fr) * | 1991-05-23 | 1994-01-21 | Roussel Uclaf | Nouveaux derives sterouides du pregna-4,9(11),17(20)-trien-3-one. |
| FR2681069B1 (fr) * | 1991-09-06 | 1995-04-28 | Roussel Uclaf | Nouveau procede de preparation de l'hydrocortisone et nouveaux intermediaires. |
| FR2683530B1 (fr) * | 1991-11-08 | 1994-01-21 | Roussel Uclaf | Nouveau procede de preparation de derives 20-oxo 17 alpha, 21-dihydroxyles du pregnane et nouveaux intermediaires. |
| JPH07503466A (ja) * | 1992-01-28 | 1995-04-13 | シェリング・コーポレーション | 新規ステロイド中間体およびその製造法 |
| CN1061984C (zh) * | 1996-04-18 | 2001-02-14 | 上海华联制药有限公司 | 甾体激素化合物中引入9-11双键的一种方法 |
| WO1999061055A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| US6855836B2 (en) * | 2000-10-26 | 2005-02-15 | Jenapharm Gmbh & Co. Kg | 17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds |
| DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| AU2008265721B2 (en) * | 2007-06-19 | 2014-03-20 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid composition, method, and preparation |
| US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| JOP20180077A1 (ar) | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
| ES2728225T3 (es) | 2009-02-20 | 2019-10-23 | 2 Bbb Medicines B V | Sistema de administración de fármacos a base de glutatión |
| EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| WO2012021133A1 (en) | 2010-08-12 | 2012-02-16 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
| WO2013044119A1 (en) * | 2011-09-22 | 2013-03-28 | Kythera Biopharmaceuticals, Inc. | Compositions and methods related to deoxycholic acid and its polymorphs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL103170C (pt) * | 1958-11-14 | |||
| DE1568506A1 (de) * | 1966-03-23 | 1970-07-16 | Hoechst Ag | Verfahren zur Herstellung von delta?-Pregnen-3,21-diol-20-on-21-acylaten |
| US3445907A (en) * | 1967-02-16 | 1969-05-27 | Ind Tectonics Inc | Roller retaining method for roller bearing separators |
| US4255344A (en) * | 1978-11-08 | 1981-03-10 | Mitsubishi Chemical Industries, Limited | 9-α-Hydroxy steroids |
| FR2462445A1 (fr) * | 1979-07-31 | 1981-02-13 | Roussel Uclaf | Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle |
| FR2486947A1 (fr) * | 1980-07-15 | 1982-01-22 | Roussel Uclaf | Nouveaux derives steroides 20-isonitriles 17(20) insatures, leur procede de preparation et leur application a la preparation des steroides 17a-hydroxy 20-ceto |
| DE3136917A1 (de) * | 1980-09-27 | 1982-05-19 | Barmag Barmer Maschinenfabrik Ag, 5630 Remscheid | "kraftstoffoerderpumpe" |
| FR2493324B1 (pt) * | 1980-11-05 | 1983-01-21 | Roussel Uclaf | |
| FR2521567A1 (fr) * | 1982-02-18 | 1983-08-19 | Roussel Uclaf | Nouveaux derives steroides 17(20)nitro, leur procede de preparation et leur application a la preparation de corticosteroides |
| EP0123734A1 (en) * | 1983-04-29 | 1984-11-07 | Gist-Brocades N.V. | 17-(Isocyano-sulfonylmethylene)-steroids, 17-(formamido-sulfonylmethylene)-steroids and their preparation |
-
1989
- 1989-04-07 AU AU34313/89A patent/AU618350B2/en not_active Expired
- 1989-04-07 KR KR1019890702133A patent/KR0138777B1/ko not_active IP Right Cessation
- 1989-04-07 DE DE8989200891T patent/DE68901104D1/de not_active Expired - Lifetime
- 1989-04-07 WO PCT/NL1989/000020 patent/WO1989009781A1/en active IP Right Grant
- 1989-04-07 JP JP1504593A patent/JP2812397B2/ja not_active Expired - Lifetime
- 1989-04-07 IL IL8988089A patent/IL89880A/en unknown
- 1989-04-07 ES ES198989200891T patent/ES2033516T3/es not_active Expired - Lifetime
- 1989-04-07 EP EP89200891A patent/EP0336521B1/en not_active Expired - Lifetime
- 1989-04-07 US US07/474,852 patent/US5194602A/en not_active Expired - Lifetime
- 1989-04-07 PT PT90227A patent/PT90227B/pt not_active IP Right Cessation
- 1989-04-07 HU HU892602A patent/HU208437B/hu unknown
- 1989-04-08 CN CN89102092A patent/CN1032211C/zh not_active Expired - Lifetime
- 1989-04-08 CN CNB951202561A patent/CN1187365C/zh not_active Expired - Lifetime
- 1989-04-10 CA CA000596257A patent/CA1332409C/en not_active Expired - Lifetime
- 1989-04-10 IE IE113489A patent/IE62277B1/en not_active IP Right Cessation
-
1990
- 1990-10-03 FI FI904877A patent/FI108436B/fi not_active IP Right Cessation
- 1990-10-05 NO NO904333A patent/NO300894B1/no not_active IP Right Cessation
- 1990-10-05 DK DK199002408A patent/DK175401B1/da not_active IP Right Cessation
-
1992
- 1992-05-08 GR GR920400800T patent/GR3004539T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU892602D0 (en) | 1991-03-28 |
| DK240890D0 (da) | 1990-10-05 |
| WO1989009781A1 (en) | 1989-10-19 |
| JP2812397B2 (ja) | 1998-10-22 |
| NO300894B1 (no) | 1997-08-11 |
| NO904333D0 (no) | 1990-10-05 |
| CN1032211C (zh) | 1996-07-03 |
| FI904877A0 (fi) | 1990-10-03 |
| CN1036774A (zh) | 1989-11-01 |
| FI108436B (fi) | 2002-01-31 |
| DE68901104D1 (de) | 1992-05-07 |
| JPH03503645A (ja) | 1991-08-15 |
| HUT55411A (en) | 1991-05-28 |
| IE62277B1 (en) | 1995-01-25 |
| DK240890A (da) | 1990-10-05 |
| PT90227B (pt) | 1994-06-30 |
| CN1141301A (zh) | 1997-01-29 |
| IL89880A (en) | 1994-06-24 |
| IL89880A0 (en) | 1989-12-15 |
| KR900700499A (ko) | 1990-08-13 |
| IE891134L (en) | 1989-10-08 |
| EP0336521A1 (en) | 1989-10-11 |
| CN1187365C (zh) | 2005-02-02 |
| EP0336521B1 (en) | 1992-04-01 |
| GR3004539T3 (pt) | 1993-04-28 |
| ES2033516T3 (es) | 1993-03-16 |
| DK175401B1 (da) | 2004-09-27 |
| KR0138777B1 (ko) | 1998-04-30 |
| NO904333L (no) | 1990-12-03 |
| AU618350B2 (en) | 1991-12-19 |
| US5194602A (en) | 1993-03-16 |
| AU3431389A (en) | 1989-11-03 |
| CA1332409C (en) | 1994-10-11 |
| HU208437B (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT90119A (pt) | Processo para a preparacao de um adocante | |
| PT93785A (pt) | Processo para a preparacao de derivados de 3-substituido-2-oxindole | |
| BR8902297A (pt) | Processo para a preparacao de 1,1,1,2-tetrafluoretano | |
| PT90293A (pt) | Processo para a preparacao de macrolidos | |
| BR8802484A (pt) | Processo para a preparacao de isocianatos | |
| PT92534A (pt) | Processo para a preparacao de compostos azabiciclicos | |
| PT90227A (pt) | Processo para a preparacao de esteroides de 9 alfa-hidroxi-17-metileno | |
| PT91068A (pt) | Processo para a preparacao de compostos biarilo | |
| PT91895A (pt) | Processo para a preparacao de 9h-purinas substituidas | |
| PT91983A (pt) | Processo para a preparacao de tintas antivegetativas | |
| PT91872A (pt) | Processo para a preparacao de compostos azabiciclicos | |
| BR8906327A (pt) | Processo para a preparacao de organoclorossilanos | |
| PT90854A (pt) | Processo para a preparacao de 1-aril-2-naftoilaminas | |
| PT90266A (pt) | Processo para a preparacao de compostos azabiciclicos | |
| PT92638A (pt) | Processo para a preparacao de poliazamacrociclos mono-n-alquilados | |
| PT92365A (pt) | Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida | |
| BR9001503A (pt) | Processo para a preparacao de alquil-halogenossilanos | |
| PT93629A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
| PT89775A (pt) | Processo para a preparacao de derivados de isoquinolina | |
| PT91027A (pt) | Processo para a preparacao de derivados peptidicos | |
| PT92539A (pt) | Processo para a preparacao de derivados de anfotericina b | |
| BR8803678A (pt) | Processo para a preparacao de polieteramidas | |
| BR8903367A (pt) | Processo para a preparacao de organoclorossilanos | |
| BR8902030A (pt) | Processo para a preparacao de n-fosfonometilglicina | |
| PT89954A (pt) | Processo para a preparacao de pirroloquinolina-e pirrolofenotiazina-carboxamidas e de compostos afins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19931206 |
|
| PC3A | Transfer or assignment |
Free format text: 19991011 HOECHST MARION ROUSSEL FR |
|
| PD3A | Change of proprietorship |
Owner name: ROUSSEL UCLAF Effective date: 19991011 |
|
| TE3A | Change of address (patent) |
Owner name: ROUSSEL UCLAF Effective date: 19991011 |
|
| PC3A | Transfer or assignment |
Free format text: AVENTIS PHARMA S. A. FR Effective date: 20041014 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20090407 |